IBI – International Biopharmaceutical Industry is a renowned brand that caters to the needs of the pharmaceutical and life sciences sectors around the world. Established by professionals with over 30 years of experience in publishing, IBI understands the dynamic nature of these industries and is committed to delivering effective marketing and communication solutions.

With a strong network and collaboration with industry associations, IBI ensures a global distribution network that reaches all stakeholders in the life sciences sector. Through our carefully selected editorial advisory panel and extensive research network, we provide the latest research and technology innovations, regulatory guidelines, marketing strategies, and communication tactics to the pharmaceutical, biopharmaceutical, nutraceutical, and medical devices industry.

Our goal is to help these industries become more efficient, bring products to market faster, reduce costs, and make healthcare accessible to all. IBI has established a strong presence globally, including in the US, Central Europe, Middle East, Latin America, Eastern Europe, Asia, and Africa, focusing on research and development, trials, manufacturing, and technology transfer.

Our target audience includes primary stakeholders within the life sciences industry who are actively involved in drug discovery and development, research, trials, manufacturing, supply chain, licensing, and marketing, as well as physician and patient communication. Trust IBI to be your reliable extension of marketing and communication, integrating our expertise with your needs to highlight your expertise effectively.